Sökning: "Late sequelae"
Visar resultat 6 - 10 av 19 avhandlingar innehållade orden Late sequelae.
6. Childhood brain tumours : health and function in adult survivors and parental fears
Sammanfattning : The general aim of the present research was to investigate health and functional ability of patients treated for childhood brain tumour and systematically examine parental fears after a child s brain tumour. The aims were realised through two part-studies. LÄS MER
7. Langerhans cell histiocytosis : a clinical and immunological study
Sammanfattning : Langerhans cell histiocytosis (LCH), previously known as histiocytosis X, eosinophilic granuloma, Hand-Schüller-Christian or Letterer-Siwe disease, is a rare disease with a reported incidence in childhood of 5.4 cases per million children per year. The disease can present at any age but young children are most often affected. LÄS MER
8. Invasive haemophilus influenzae infection. Clinical, immunologic and pathogenic aspects
Sammanfattning : Invasive Haemophilus influenzae (Hi) infection, predominantly manifested as acute meningitis and epiglottitis, is a serious disease with associated mortality and residual handicap. Prevention of the disease is possible by vaccination against Hi serotype b (Hib). LÄS MER
9. Studies on venous function after deep venous thrombosis
Sammanfattning : Background: The incidence of deep venous thrombosis (DVT) is estimated to be about 1-2/1000 per year of which approximately 4 % are located in the arm veins. Some of the most important late effects of a DVT are chronic venous dysfunction and the development of post-thrombotic syndrome (PTS). LÄS MER
10. Studies of cerebral blood flow and cerebrospinal fluid in childhood acute lymphoblastic leukemia
Sammanfattning : Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and more than 80% of the patients are cured today. Treatment might cause side effects and central nervous system (CNS) irradiation has been replaced by systemic high-dose methotrexate (MTX) and intrathecal (IT) MTX due to the risk of late effects. LÄS MER